Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of Long Term Peg-Intron for Patients Who Have Failed to Respond to Rebetron/Interferon With Advanced Fibrosis and Cirrhosis Secondary to Hepatitis C- The Copilot Trial

NCT00179413 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT00179413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00179413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of Long Term Peg-Intron for Patients Who Have Failed to Respond to Rebetron/Interferon With Advanced Fibrosis and Cirrhosis Secondary to Hepatitis C- The Copilot Trial
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Phase 4
Overall status
Completed
Start date
January 15, 2000
Completion date
March 3, 2010
Enrollment
549 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

advanced fibrosis, cirrhosis, hepatitis c virus